Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration

S. Sutcliffe, R. L. Nevin, R. Pakpahan, D. J. Elliott, S. R. Cole, A. M. De Marzo, C. A. Gaydos, W. B. Isaacs, W. G. Nelson, L. J. Sokoll, J. M. Zenilman, S. B. Cersovsky, E. A. Platz

Research output: Contribution to journalArticlepeer-review

Abstract

Background: We investigated prostate involvement during sexually transmitted infections by measuring serum prostate-specific antigen (PSA) as a marker of prostate infection, inflammation, and/or cell damage in young, male US military members. Methods: We measured PSA before and during infection for 299 chlamydia, 112 gonorrhoea, and 59 non-chlamydial, non-gonococcal urethritis (NCNGU) cases, and 256 controls. Results: Chlamydia and gonorrhoea, but not NCNGU, cases were more likely to have a large rise (40%) in PSA than controls (33.6%, 19.1%, and 8.2% vs 8.8%, P0.0001, 0.021, and 0.92, respectively). Conclusion: Chlamydia and gonorrhoea may infect the prostate of some infected men.

Original languageEnglish (US)
Pages (from-to)602-605
Number of pages4
JournalBritish journal of cancer
Volume105
Issue number5
DOIs
StatePublished - Aug 23 2011

Keywords

  • chlamydia
  • gonorrhoea
  • non-chlamydial
  • non-gonococcal urethritis
  • prostate cancer
  • prostate-specific antigen
  • sexually transmitted infections

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration'. Together they form a unique fingerprint.

Cite this